Prescription drug · NDA
TobraDex (Tobramycin and dexamethasone) NDC 0078-0876
Tobramycin 3 mg/g; Dexamethasone 1 mg/g · Ointment · Ophthalmic · Novartis Pharmaceuticals Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0078-0876-01 | 0007808760100078087601 | 3.5 g in 1 TUBE (0078-0876-01)Marketed from Oct 27, 2020 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- TobraDex
- Generic name (nonproprietary)
- tobramycin and dexamethasone
- Active ingredients
- Tobramycin — 3 mg/gDexamethasone — 1 mg/g
- Dosage form
- Ointment
- Route
- Ophthalmic
- Labeler
- Novartis Pharmaceuticals CorporationNDC labeler code 0078
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 050616
- Marketing start
- Listing expires
- Other FDA classes
- Aminoglycosides (Chemical structure)Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 0078-0876_81fcc79f-0170-4a8c-a938-f440a3d48dbfSPL ID 81fcc79f-0170-4a8c-a938-f440a3d48dbfSPL set ID 7f310e0e-0d3b-493d-b6c4-238493a2a9b9RxCUI 208821, 309682UNII VZ8RRZ51VK, 7S5I7G3JQL
- Pharmacologic class
- Aminoglycoside Antibacterial; Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400078087601followed by a unit qualifier and the quantityPackage 00078-0876-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: TOBRADEX (tobramycin and dexamethasone ophthalmic ointment) is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of for…
Excerpt only. Read the full label for complete information.
About NDC 0078-0876
- What is NDC 0078-0876?
- 0078-0876 is the product NDC for TobraDex, Tobramycin 3 mg/g; Dexamethasone 1 mg/g ointment, listed with the FDA by Novartis Pharmaceuticals Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- TobraDex (Tobramycin and dexamethasone).
- What is the active ingredient?
- Tobramycin, Dexamethasone.
- Who is the labeler?
- Novartis Pharmaceuticals Corporation, NDC labeler code 0078. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for TobraDex?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.